Trial · NCT00951561
A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
NCT00951561, Not applicable, Completed, Another Way Products; results first posted 2010-10-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen. Trials, record NCT00951561. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00951561
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
- NCT number
- NCT00951561
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 115 participants, actual
- Lead sponsor
- Another Way Products
- Conditions
- Dysmenorrhea
- Interventions
- Vipon, Ibuprofen
- First posted
- 2009-08-04
- Last updated
- 2011-06-16
- Results first posted
- 2010-10-04
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model | 1 month, 2 months, 3 months, 4 months | Modified Melzack-McGill Scale measures general pain (0=none, 1-3=mild, 4-6=moderate, 7-9=severe, 10=worst pain) Total Number of Uses Analyzed is a sum of the Number of Uses collected at each time point. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model | 1 month, 2 months, 3 months, 4 months | Statistical analysis was carried out per plan. | percentage of uses | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model | VIPON | 73.8 | percentage of uses | ||
| Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model | Ibuprofen | 75.5 | percentage of uses |
Source ClinicalTrials.gov
Participant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Vipon/Ibuprofen/Vipon/Ibuprofen | 25 | |
| Overall Study | STARTED | Ibuprofen/Vipon/Ibuprofen/Vipon | 29 | |
| Overall Study | STARTED | Vipon/Ibuprofen/Ibuprofen/Vipon | 21 | |
| Overall Study | STARTED | Ibuprofen/Vipon/Vipon/Ibuprofen | 27 | |
| Overall Study | COMPLETED | Vipon/Ibuprofen/Vipon/Ibuprofen | 25 | |
| Overall Study | COMPLETED | Ibuprofen/Vipon/Ibuprofen/Vipon | 29 | |
| Overall Study | COMPLETED | Vipon/Ibuprofen/Ibuprofen/Vipon | 18 | |
| Overall Study | COMPLETED | Ibuprofen/Vipon/Vipon/Ibuprofen | 26 | |
| Overall Study | NOT COMPLETED | Vipon/Ibuprofen/Vipon/Ibuprofen | 0 | |
| Overall Study | NOT COMPLETED | Ibuprofen/Vipon/Ibuprofen/Vipon | 0 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Acne | Skin and subcutaneous tissue disorders | Study Participants | 1 | 102 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Study Participants | 1 | 102 | 1 |
| other | Anxiety | Psychiatric disorders | Study Participants | 1 | 102 | 2 |
| other | Back ache | Musculoskeletal and connective tissue disorders | Study Participants | 2 | 102 | 2 |
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Study Participants | 3 | 102 | 3 |
| other | Cellulitis | Infections and infestations | Study Participants | 1 | 102 | 2 |
| other | Chest congestion | Respiratory, thoracic and mediastinal disorders | Study Participants | 1 | 102 | 1 |
| other | Chest pain | General disorders | Study Participants | 1 | 102 | 1 |
| other | Chills | General disorders | Study Participants | 1 | 102 | 1 |
| other | Cold | General disorders | Study Participants | 1 | 102 | 1 |
1 to 10 of 60Source ClinicalTrials.gov
See all 60 adverse eventsAdverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Study Participants | ||
| Total, other adverse events | Study Participants | 48 | 102 |
| Total, serious adverse events | Study Participants | 2 | 102 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00951561
GET https://conductscience.org/api/trials/v1/NCT00951561/events?page=2